Xpert Bladder Cancer Monitorto Predict Need for 2nd TURBMoniTURB Trial”

• Conditions: C67; Malignant neoplasm of bladder

• Registration Number: DRKS00014974
• Lead Sponsor: Cepheid Europe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• patients 18 years or older, who provide written informed consent
• patients with endoscopically diagnosed urinary bladder tumor (primary or recurrent)
• Sceduled TUR-B within 6 weeks after enrollement

Exclusion Criteria

• BCG (Bacillus Calmette-Guerin) Instillation 6 weeks prior to TUR-B/Re-TUR-B

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malignant tumor at second TUR-B

Secondary Outcome Measures

Name	Time	Method
Recurrence-free survival